Gold tier: mechanically validated evidence, with its primary source.
787 evidence items · page 6 / 32
Oral artemisinin derivative treatments for uncomplicated P. falciparum malaria are associated with a transient and clinically moderate haemoglobin decrease by day 7.
Malipaludismeobserved day 7published 2014Malaria journaleurope_pmcdocument of 4 observationsDOI 10.1186/1475-2875-13-358
30 %The mean proportion of severe malaria cases reported between 2017 and 2022 was 30%.
Malipaludismeobserved 2017–2022HAL · Unilimdocument of 111 observations
3,204,130 casesBetween 2021 and 2022, the number of malaria cases in Mali rose from 3,204,130 to 3,770,000.
Malipaludismeobserved 2021HAL · Unilimdocument of 111 observations
29 joursYoung et Burgess ont rapporté une période pré-patente de 29 jours pour P. malariae.
MalipaludismeHAL · Unilimdocument of 214 observations
28.7 %Malaria infection prevalence was 28.7% in 2012 among children in the health district of Koutiala, Mali.
Malipaludismeobserved 2012published 2020International journal of environmental research and public healtheurope_pmcdocument of 7 observationsDOI 10.3390/ijerph17186639
Au Mali, le paludisme est saisonnier avec un pic d'incidence des cas cliniques et de mortalité entre septembre et novembre.
Malipaludismeobserved septembre-novembreHAL · Unilimdocument of 214 observations
1.9 per_1000SMC was associated with a 1.9 ‰ reduction in malaria incidence in the general population of Mali.
MalipaludismeHAL · Unilimdocument of 111 observations
28.5 %Parmi 28 échantillons examinés, les schizontes ont été trouvés dans 8 échantillons, soit 28,5 %.
MalipaludismeHAL · Unilimdocument of 214 observations
70 %A pilot study conducted in the central region of Segou found indoor residual spraying (IRS) reduced malaria incidence by 70%.
MalipaludismeHAL · Unilimdocument of 111 observations
66.8 %Hospital admissions for WHO-defined severe malaria were reduced by 66.8% in the combined RTS,S/AS01 E and SMC group compared with the SMC alone group.
Malipaludismepublished 2024The Lancet. Infectious diseaseseurope_pmcdocument of 12 observationsDOI 10.1016/s1473-3099(23)00368-7
3 %Le Mali contribue à 3 % des cas et décès mondiaux dus au paludisme.
MalipaludismeHAL · Unilimdocument of 214 observations
0.944 nMP. ovale isolates showed no significant difference in susceptibility to cabamiquine compared to P. falciparum, with a median IC50 of 0.9441 nM.
Malipaludismepublished 2026BMC infectious diseaseseurope_pmcdocument of 4 observations
37,372 parasites/μLLa parasitémie moyenne pour les infections à Plasmodium falciparum chez les individus symptomatiques était de 37 372 parasites/μL.
MalipaludismeHAL · Unilimdocument of 214 observations
28.5 %Among children with sickle cell trait in Mali, the prevalence of severe versus uncomplicated malaria in heterozygous females with the G6PD (A−) polymorphism was 28.5%.
MaliG6PD (A−) polymorphism · paludisme · trait drépanocytairepublished 2011American Journal of HematologyOpenAlexdocument of 9 observationsDOI 10.1002/ajh.22093
77.4 %Cross-reactive antibodies against S were present in 77.4% of BS− samples (42 out of 62).
MalipaludismeHAL · Unilimdocument of 67 observations
2,951,036 testsOver the 2018–2022 period, 15% (2,951,036) of suspected malaria cases in Mali were tested by thick blood smear microscopy.
Malipaludismeobserved 2018–2022HAL · Unilimdocument of 111 observations
78.2 %In Part B of the trial, Plasmodium falciparum infections were detected on blood-smear examination in 86 participants (78.2%) who received placebo.
Malipaludismepublished 2022The New England journal of medicineeurope_pmcdocument of 5 observations
Artemether-lumefantrine showed comparable therapeutic efficacy in children without severe acute malnutrition and in those with severe acute malnutrition when given in combination with ready-to-use therapeutic food.
Malipaludismepublished 2016BMC medicineeurope_pmcdocument of 5 observations
5.64 %La fréquence de Plasmodium malariae était plus élevée chez les participants asymptomatiques (5,64 %) que chez ceux présentant des symptômes cliniques (2,45 %).
MalipaludismeHAL · Unilimdocument of 214 observations
78.5 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 78.5% showed a 2-fold increase in anti-CSP IgG antibody titres post-2021 as measured by GSK ELISA.
Burkina Faso · Malipaludismeobserved post-2021HAL · Unilimdocument of 105 observations
92.9 %The level of Plasmodium falciparum clinical response to Artesunate-Amodiaquine was 92.9% (156/168) of Adequate Clinical and Parasitological Response before molecular correction.
Malipaludismepublished 2021The Journal of parasitologyeurope_pmcdocument of 8 observations
12.4 %Malaria infection prevalence was 12.4% in 2014 among children in the health district of Koutiala, Mali.
Malipaludismeobserved 2014published 2020International journal of environmental research and public healtheurope_pmcdocument of 7 observationsDOI 10.3390/ijerph17186639
0.9 %For the final 16-month follow-up period, vaccine efficacy was 0.9% against all malaria episodes.
Malipaludismepublished 2013PloS oneeurope_pmcdocument of 2 observations
65.2 %Malaria prevalence from all Plasmodium species was 65.20% in passive screening.
Malipaludismepublished 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 16 observations
25 childrenPlasmodium vivax was detected in 25 Duffy-negative children in Bandiagara, Mali.
Malipaludismepublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 4 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.